![Frank Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Lee
Chief Executive Officer at
PACIRA BIOSCIENCES, INC.
Net worth: 16 M $ as of 30/05/2026
Profile
Frank D.
Lee is currently Chief Executive Officer & Director at Pacira Biosciences, Inc. since 2024, Chief Executive Officer & Director at Flexion Therapeutics, Inc., Executive Chairman at Therini Bio, Inc. since 2023, Chairman at Catamaran Bio, Inc. since 2022, Independent Director at Bausch Health Cos., Inc. since 2024, and Advisor at LSV Capital Management LLC since 2023.
Former roles include President, Chief Executive Officer & Director at Forma Therapeutics Holdings, Inc. and Forma Therapeutics, Inc. from 2019 to 2022, Director at The Genentech Foundation, Independent Director at Bolt Biotherapeutics, Inc. from 2021 to 2024, Senior Vice President-Global Product Strategy at Genentech, Inc. from 2006 to 2019, and Member at Roche Group.
Education includes an undergraduate degree from Vanderbilt University in 1996 and an MBA from The Wharton School of the University of Pennsylvania in 1989.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 16/04/2026 | 660,830 ( 1.68% ) | 15 M $ | 30/05/2026 | |
| 21/05/2026 | 95,210 ( 0.03% ) | 510 326 $ | 30/05/2026 |
Frank Lee active positions
| Companies | Position | Start |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Chief Executive Officer | 01/01/2024 |
| BAUSCH HEALTH COMPANIES INC. | Director/Board Member | 13/05/2024 |
| FLEXION THERAPEUTICS, INC. | Chief Executive Officer | - |
Catamaran Bio, Inc.
 Catamaran Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company developing allogeneic, off the shelf CAR-NK cell therapies for cancer treatment | Chairman | 04/04/2022 |
Therini Bio, Inc.
 Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in halt chronic neuroinflammation and neuronal damage caused by vascular injury to treat severe neurological & retinal diseases | Chairman | 14/05/2023 |
LSV CAPITAL MANAGEMENT LLC
 LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, biotech, and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Consultant / Advisor | 31/01/2023 |
Former positions of Frank Lee
| Companies | Position | End |
|---|---|---|
| BOLT BIOTHERAPEUTICS, INC. | Director/Board Member | 02/09/2024 |
Forma Therapeutics, Inc.
 Forma Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer and other genetically driven diseases | Chief Executive Officer | 30/09/2022 |
| FORMA THERAPEUTICS HOLDINGS, INC. | Chief Executive Officer | 30/09/2022 |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Frank Lee
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
98
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Forma Therapeutics, Inc.
Forma Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer and other genetically driven diseases | Health Technology |
Forma Therapeutics Holdings, Inc.
 Forma Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes novel therapeutics to transform the patient living | Health Technology |
Vanderbilt University
 Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pacira Biosciences, Inc.
 Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
Roche Group
 Roche Group Real Estate DevelopmentFinance Manages real estate properties | Finance |
The Genentech Foundation
 The Genentech Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Bausch Health Cos., Inc.
 Bausch Health Cos., Inc. Pharmaceuticals: OtherHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
LSV CAPITAL MANAGEMENT LLC
LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, biotech, and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bolt Biotherapeutics, Inc.
 Bolt Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Therini Bio, Inc.
Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in halt chronic neuroinflammation and neuronal damage caused by vascular injury to treat severe neurological & retinal diseases | Commercial Services |
Catamaran Bio, Inc.
Catamaran Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company developing allogeneic, off the shelf CAR-NK cell therapies for cancer treatment | Health Technology |
- Stock Market
- Insiders
- Frank Lee
Choose MarketScreener 
